Genetic association study in nasal polyposis

Journal of Investigational Allergology and Clinical Immunology

Volumn 22, Issue 5, 2012, Pages 331-340

  Benito Pescador, D ^a   Isidoro Garcia M ^a,b   Garcia Solaesa V ^a   Pascual de Pedro, M ^a   Sanz, C ^b   Hernandez Hernandez L ^a   Sanchez Lopez J ^c   Lorente, F ^a,b   Picado, C ^c   Valero, A ^c   Davila I ^a  

^a HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^b UNIVERSITY OF SALAMANCA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

Author keywords

Asthma; Atopy; CYSLTR1; LTC4S; Nasal polyposis; NOS2A; PTGDR; SNP

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; LEUKOTRIENE C4 SYNTHASE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ALLELE; ALLERGIC ASTHMA; ARTICLE; ATOPY; CASE CONTROL STUDY; CONTROLLED STUDY; CYSTEINYL LEUKOTRIENE RECEPTOR 1 GENE; DISEASE ASSOCIATION; DRUG TOLERABILITY; FEMALE; GENE; GENE FREQUENCY; GENE LOCATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; INDUCIBLE NITRIC OXIDE SYNTHASE GENE; LEUKOTRIENE C4 SYNTHETASE GENE; MAJOR CLINICAL STUDY; MALE; NOSE POLYP; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; EPISTASIS, GENETIC; GENETIC ASSOCIATION STUDIES; GENOTYPE; HAPLOTYPES; HUMANS; NASAL POLYPS; NITRIC OXIDE SYNTHASE TYPE II; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84864810278     PISSN: 10189068     EISSN: 16980808     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Hamilos DL. Chronic rhinosinusitis: Epidemiology and medical management. J Allergy Clin Immun. 2011;128(4):693-707.
2. Greisner WA, Settipane GA. Hereditary Factor for Nasal Polyps. Allergy Asthma Proc. 1996;17:283-6.
3. Rugina M, Serrano E, Klossek JM, et al. Epidemiological and clinical aspects of nasal polyposis in France; the ORLI group experience. Rhinology. 2002;40(2):75-9.
4. Molnar-Gabor E, Endreffy E, Rozsasi A. HLA-DRB1,-DQA1, and-DQB1 genotypes in patients with nasal polyposis. Laryngoscope. 2000;110(3):422-5.
5. Moloney JR, Oliver RT. HLA antigens, nasal polyps and asthma. Clin Otolaryngol Allied Sci. 1980;5(3):183-9.
6. Jacobs RL, Freda AJ, Culver WG. Primary nasal polyposis. Palatine, IL, U.S.A.: American College of Allergy and Immunology; 1983.
7. Mfuna Endam L, Cormier C, Bosse Y, Filali-Mouhim A, Desrosiers M. Association of IL1A, IL1B, and TNF gene polymorphisms with chronic rhinosinusitis with and without nasal polyposis: A replication study. Arch Otolaryngol Head Neck Surg. 2010;136(2):187-92.
8. Yea SS, Yang YI, Park SK, Jang WH, Lee SS, Seog DH, Park YH, Chun JH. Interleukin-4 C-590T polymorphism is associated with protection against nasal polyps in a Korean population. Am J Rhinol. 2006;20:550-3.
9. Liu Z, Kim J, Sypek JP, Wang IM, Horton H, Oppenheim FG, Bochner BS. Gene expression profiles in human nasal polyp tissues studied by means of DNA microarray. J Allergy Clin Immunol. 2004;114(4):783-90.
10. Wang X, Dong Z, Zhu DD, Guan B. Expression profile of immune-associated genes in nasal polyps. Ann Oto Rhinol Laryn. 2006;115(6):450-6.
11. Baenkler HW, Schäfer D, Hosemann W. Eicosanoids from biopsy of normal and polypous nasal mucosa. Rhinology. 1996;34(3):166-70.
12. Adamjee J, Suh YJ, Park SH, Choi JH, Penrose JF, Lam BK, Austen KF, Cazaly AM, Wilson SJ, Sampson AP. Expression of 5-lipoxygenase and cyclooxygenase pathway enzymes in nasal polyps of patients with aspirin-intolerant asthma. J Pathol. 2006;209(3):392-9.
13. Tantisira KG, Drazen JM. Genetics and pharmacogenetics of the leukotriene pathway. J Allergy Clin Immunol. 2009 Sep;124(3):422-7.
14. Isidoro-García M, Dávila I, Moreno E, Lorente F, González-Sarmiento R. Analysis of the leukotriene C4 synthase A444C promoter polymorphism in a Spanish population. J Allergy Clin Immunol. 2005;115(1):206-7.
15. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347(19):1493-9.
16. Yoshimura T, Yoshikawa M, Otori N, Haruna S, Moriyama H. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. Allergol Int. 2008;57(4):429-36.
17. Narumiya S. Prostanoids and inflammation: a new concept arising from receptor knockout mice. J Mol Med. 2009;87(10):1015-22.
18. Pérez-Novo C, Claeys C, Van Cauwenberge P, Bachert C. Expression of eicosanoid receptors subtypes and eosinophilic inflammation: implication on chronic rhinosinusitis. Respiratory Research. 2006;7(1):75.
19. Parikh A, Scadding GK, Gray P, Belvisi MG, Mitchell JA. High levels of nitric oxide synthase activity are associated with nasal polyp tissue from aspirin-sensitive asthmatics. Acta Otolaryngol. 2002;122:302-5.
20. Pascual M, Sanz C, Isidoro-García M, et al. (CCTTT)n polymorphism of NOS2A in nasal polyposis and asthma: a case-control study. J Invest Allerg Clin. 2008;18(4):239-44.
21. Qidwai T, Jamal F. Inducible nitric oxide synthase (iNOS) gene polymorphism and disease prevalence. Scand J Immunol. 2010;72(5):375-87.
22. Batikhan H, Gokcan M, Beder E, Akar N, Ozturk A, Gerceker M. Association of the tumor necrosis factor-alpha-308 G/A polymorphism with nasal polyposis. Eur Arch Otorhinolaryngol. 2010;267(6):903-8.
23. Cheong HS, Park SM, Kim MO, et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy. 2011;66(5):637-44.
24. Wang L-F, Chien C-Y, Tai C-F, Kuo W-R, Hsi E, Juo S-H. Matrix metalloproteinase-9 gene polymorphisms in nasal polyposis. BMC Medical Genetics. 2010;11(1):85.
25. Fokkens W, Lund V, Mullol J. European Position Paper on Rhinosinusitis and Nasal Polyps. Rhinology. 2007;45(2):97-101.
26. Sanz C, Isidoro-García M, Dávila I, Moreno E, Laffond E, Ávila C, Lorente F. Promoter genetic variants of prostanoid DP receptor PTGDR gene in patients with asthma. Allergy. 2006;61(5):543-8.
27. Sanz C, Isidoro-García M, Dávila I, Moreno E, Laffond E, Lorente F. Analysis of 927T > C CYSLTRI and-444A > C LTC4S Polymorphisms in Patients with Asthma. J Invest Allerg Clin. 2006;16(6):331-7.
28. Li Z, Zhang Z, He Z, Tang W, Li T, Zeng Z, He L, Shi Y. A partitionligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: update of the SHEsis (http:// analysis.bio-x.cn). Cell Res. 2009;19(4):519-23.
29. Yoo J, Seo B, Kim Y. SNPAnalyzer: a web-based integrated workbench for single-nucleotide polymorphism analysis. Nucleic Acids Res. 2005;33(2):483-8.
30. Min YG, Lee CH, Rhee CS, Kim KH, Kim CS, Koh YY, Min KU, Anderson PL. Inflammatory cytokine expression on nasal polyps developed in allergic and infectious rhinitis. Acta Otolaryngol. 1997;117(2):302-6.
31. Sanz C, Isidoro-García M, Dávila I, de Pedro MP, Méndez Sde A, Padrón J, Ruiz-SanFrancisco A, Lorente F. A new PTGDR promoter polymorphism in a population of children with asthma. Pediatr Allergy Immu. 2009;20:151-6.
32. Oguma T, Palmer LJ, Birben E, Sonna LA, Asano K, Lilly CM. Role of prostanoid DP receptor variants in susceptibility to asthma. N Engl J Med. 2004;351(17):1752-63.
33. Kawaguchi Y, Tochimoto A, Hara M, Kawamoto M, Sugiura T, Katsumata Y, Okada J, Kondo H, Okubo M, Kamatani N. NOS2 polymorphisms associated with the susceptibility to pulmonary arterial hypertension with systemic sclerosis: contribution to the transcriptional activity. Arthritis Res Ther. 2006;8(4):104.
34. Furukawa K, Harrison D, Saleh D, Shennib H, Chagnon F, Giaid A. Expression of nitric oxide synthase in the human nasal mucosa. Am J Respir Crit Care Med. 1996;153(2):847-50.
35. Batra J, Pratap Singh T, Mabalirajan U, Sinha A, Prasad R, Ghosh B. Association of inducible nitric oxide synthase with asthma severity, total serum immunoglobulin E and blood eosinophil levels. Thorax. 2007;62(1):16-22.
36. Rostkowska-Nadolska B, Kapral M, Fraczek M, Kowalczyk M, Gawron W, Mazurek U. A microarray study of gene expression profiles in nasal polyps. Auris Nasus Larynx. 2011;38(1):58-64.